ILMN / Illumina hit with record fine for closing Grail deal without EU regulatory approval

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Ligand Pharmaceuticals (LGND) or Illumina ( more_horizontal

Investors need to pay close attention to Illumina (ILMN) stock based on the movements in the options market lately. more_horizontal

Activist-investor Carl Icahn said his firm had sued current and former board directors at Illumina concerning the acquisition of gene-sequencing compa more_horizontal

Illumina Inc. ILMN, -1.10% responded Friday to an order it received Thursday from the European Commission directing the company to divest its $7.1 bil more_horizontal

Illumina said on Friday it would divest cancer test maker Grail in 12 months, according to the terms of the order by the European Commission, if it do more_horizontal

Illumina Inc (NASDAQ:ILMN), a genetic testing company, has been ordered by EU antitrust regulators to sell Grail after closing its takeover of the can more_horizontal

U.S. genetic testing company Illumina has been ordered by EU antitrust regulators to sell cancer test maker Grail after it completed the deal before s more_horizontal

Illumina Inc said on Wednesday it will divest Grail if the company loses the final appeals in U.S. or European courts. more_horizontal